24th Joint Meeting of the British Endocrine Societies

Programme: Monday 4th April

Mon 4 Apr | Tues 5 Apr | Wed 6 Apr | Attended Posters

Acrobat Icon Download Programme (pdf) (1.36mb)


 

Registration
from 09.00 Main Foyer
   
Pfizer Ltd Satellite Session
11.00-12.00 Main Auditorium
Critical issues in adolescent endocrinology: from genetics to transitional care
 
LUNCH
12.00-12.30 Hall D
   
Society for Endocrinology Dale Medal Lecture
12.30-13.15 Main Auditorium       Chair: Bloom SR (London)
S1 12.30 A genetic analysis of insulin and diabetes regulated gene expression
Kahn CR (Boston, USA)
 
Symposium 1: Endocrine complications of systemic disorders
13.15-14.45 Queen's Suite 1       Chair: Wass JAH (Oxford)
S6 13.15 The metabolic effects of antiretroviral therapy
Danner S (Amsterdam, The Netherlands)
 
S7 13.45 Parathyroid hormone in children with chronic renal failure
Rees L (London)
 
S8 14.15 The endocrinology of critical care
Cooper MS (Birmingham)
 
Symposium 2: The endocrinology of the kidney
13.15-14.45 Queen's Suite 2       Chair: Pearce S (Newcastle)
S9 13.15 Lessons from the genetic hypercalciuric stone forming rat
Bushinsky DA (New York, USA)
 
S10 13.45 Regulating PTH responses in the kidney
Friedman PA (Pittsburgh, USA)
 
S11 14.15 The WNK kinases: novel regulations of sodium and potassium transport in the kidney
O’Shaughnessy K (Cambridge)
 
Clinical Management Workshop 1: Diagnosis and management of steroid deficiency
13.15-14.45 Main Auditorium       Chair: Howlett T (Leicester)
S38 13.15 Why is the management of corticosteroid deficiency still controversial?
Lightman SL (Bristol)
 
S39 13.45 Diagnosing the suppressed adrenal
Stewart PM (Birmingham)
 
S40 14.15 Glucocorticoid resistance
Lamberts S (Rotterdam, The Netherlands)
 
TEA
14.45-15.15 Hall D
   
Symposium 3: Thyroid disease in pregnancy and childhood
15.15-17.30 Main Auditorium       Chair: Lazarus J (Cardiff)
S12 15.15 Maternal thyroid dysfunction
Weetman A (Sheffield)
 
S13 15.45 Maternal and placental control of thyroid hormone availability for the foetus
Köhrle J (Berlin, Germany)
 
S14 16.15 Neuropsychological consequences of thyroid hormone deficiency
Rovet J (Toronto, Canada)
 
S15 16.45 Diagnosis and management of thyroid dysfunction in childhood
Grüters-Kieslich A (Berlin, Germany)
Oral Communications 1: Diabetes and metabolism
15.15-17.30 Queen's Suite 1       Chairs: Bloom SR (London) & White A (Manchester)
OC1 15.15 Plasticity in myogenesis and skeletal muscle metabolism via insulin and IGF receptor-mediated Akt activation
Gonzalez I, Cosgrove RA, & Pell JM
 
OC2 15.30 The relationship of beta-cell function with age: effect of population migration
Heald AH, Anderson SG, Patel J, Rudenski A, Vyas A, Laing I, Hughes E, Prabharakan D, Durrington P & Gibson JM
 
OC3 15.45 Depot specific glucocorticoid regulation of key components of the insulin signalling cascade in human adipose tissue
Gathercole LL, Bujalska IJ, Stewart PM & Tomlinson JW
 
OC4 16.00 Effect of cholesterol depletion on IGF-induced cell survival: the role of caveolar and non-caveolar domains
Matthews LC, Taggart MJ & Westwood M
 
OC5 16.15 Changes in gut hormones after Roux-en-Y gastric bypass for morbid obesity favour an anorectic state
Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG & Aylwin SJB
 
OC6 16.30 Analysis of post-translational processing and trafficking of agouti-related protein
Pritchard LE, Creemers JWM, Gyte A, Davies N, Le Rouzic P, Lawrence C, Luckman S, Brennand JC & White A
 
OC7 16.45 Calcitonin gene-related peptide (CGRP) II mRNA in human subcutaneous adipose tissue is altered by menopausal status
Gupta P, Harte AL, Hill MJ, Barnett AH, Sturdee DW, Kumar S & McTernan PG
 
OC8 17.00 Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY (3-36) on food intake
Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA & Bloom SR
 
OC9 17.15 Testosterone improves functional capacity and symptoms in men with chronic heart failure: a double-blind placebo-controlled trial
Malkin CJ, Pugh PJ, Jones RD, van Beek E, West JN, Channer KS & Jones TH
 
Oral Communications 2: Reproduction and growth
15.15-17.30 Queen's Suite 2       Chairs: Franks SJ (London) and Mason H (London)
OC10 15.15 Glucocorticoid-induced apoptosis in human decidua: a novel role for 11 beta-hydroxysteroid dehydrogenase in late gestation
Chan JCY, Evans KN, Innes B, Bulmer JN, Stewart PM, Hewison M & Kilby MD
 
OC11 15.30 A defect in the DHEA-DHEAS shuttle defines a novel cause of polycystic ovary syndrome
Arlt W, Hammer F, Filko D, Chalder SM, Hughes BA, Sanning P, Schofl C & Stewart PM
 
OC12 15.45 Direct inflammatory action of triiodothyronine on human ovarian surface epithelial cells in vitro
Rae MT, Gubbay O, Kostogiannou A, Niven D, Critchley HOD & Hillier SG
 
OC13 16.00 A novel autocrine/paracrine inside-out signalling pathway that cross-talks the prostanoid and GnRH receptors in pituitary cells
Naor Z, Naidich M, Pawson AJ, Morgan K, Battersby S, MacPherson S, Millar M, Jabbour HN & Millar RP
 
OC14 16.15 Pathophysiology and genetics of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency
Dhir V, Ivison HE, Walker EA, Draper ND, Hammer F, Malunowicz EM, Stewart PM, Shackleton CHL & Arlt W
 
OC15 16.30 Early preantral follicle development in polycystic ovaries (PCO) differs according to ovulatory status
Franks S, Stubbs S, Webber LJ & Hardy K
 
OC16 16.45 A densitometric and architectural analysis of the skeleton in adults with varying degrees of GH deficiency
Murray RD, Adams JE & Shalet SM
 
OC17 17.00 Disruption of intramembranous and endochondral bone development in TRalpha 2 null mice
Bassett JHD, O'Shea PJ, Nordstrom K, Vennstrom B & Williams GR
 
Clinical Endocrinology Trust Visiting Professor Lecture
17.30-18.15 Main Auditorium       Chair: Rees L (London)
S2 17.30 Growth hormone - not only for growth, but for life?
Christiansen JS (Aarhus, Denmark)
 
Welcome Reception
18.30-19.15 Hall D
   
Buffet and Boogie
19.30-late Bar Med (ticket only)